Centenarians maintain selective naïve T cells, expand cytotoxic CD4+ and CD8+ subsets, and demonstrate tightly regulated inflammatory signaling alongside enhanced oxidative-stress resistance and preserved epigenetic regulation. This challenges the conventional view of immunosenescence as uniform decline, revealing instead trajectory-dependent adaptive remodeling that maintains immune equilibrium. The centenarian immune phenotype represents a fundamental shift in aging biology understanding. Rather than fighting immune aging, exceptional longevity appears to embrace strategic immune adaptation. This finding reframes therapeutic targets from preserving youthful immune function to supporting balanced immune equilibrium. The implications for healthspan extension are profound—interventions should focus on maintaining adaptive capacity rather than preventing all immune changes. However, the research faces significant limitations: centenarian cohorts are inherently small and heterogeneous, making patterns difficult to validate. The lack of harmonized multi-omic longitudinal data constrains our ability to identify which adaptive changes are protective versus compensatory. While promising for developing biological-age biomarkers and informing senotherapeutic strategies, translating centenarian immune wisdom into actionable interventions for the broader population remains a complex challenge requiring more systematic study.